Mandal Abhirup, Clegg John R, Anselmo Aaron C, Mitragotri Samir
John A. Paulson School of Engineering and Applied Sciences Harvard University Cambridge Massachusetts USA.
Wyss Institute for Biologically Inspired Engineering, Harvard University Cambridge Massachusetts USA.
Bioeng Transl Med. 2020 Apr 3;5(2):e10158. doi: 10.1002/btm2.10158. eCollection 2020 May.
Injectable hydrogels are one of the most widely investigated and versatile technologies for drug delivery and tissue engineering applications. Hydrogels' versatility arises from their tunable structure, which has been enabled by considerable advances in fields such as materials engineering, polymer science, and chemistry. Advances in these fields continue to lead to invention of new polymers, new approaches to crosslink polymers, new strategies to fabricate hydrogels, and new applications arising from hydrogels for improving healthcare. Various hydrogel technologies have received regulatory approval for healthcare applications ranging from cancer treatment to aesthetic corrections to spinal fusion. Beyond these applications, hydrogels are being studied in clinical settings for tissue regeneration, incontinence, and other applications. Here, we analyze the current clinical landscape of injectable hydrogel technologies, including hydrogels that have been clinically approved or are currently being investigated in clinical settings. We summarize our analysis to highlight key clinical areas that hydrogels have found sustained success in and further discuss challenges that may limit their future clinical translation.
可注射水凝胶是药物递送和组织工程应用中研究最广泛、用途最广泛的技术之一。水凝胶的多功能性源于其可调节的结构,这得益于材料工程、聚合物科学和化学等领域的重大进展。这些领域的进展不断带来新聚合物的发明、交联聚合物的新方法、制造水凝胶的新策略以及水凝胶在改善医疗保健方面的新应用。各种水凝胶技术已获得监管批准,用于从癌症治疗到美容矫正再到脊柱融合等医疗保健应用。除了这些应用,水凝胶正在临床环境中用于组织再生、尿失禁和其他应用的研究。在这里,我们分析了可注射水凝胶技术的当前临床情况,包括已获得临床批准或目前正在临床环境中研究的水凝胶。我们总结分析结果,以突出水凝胶取得持续成功的关键临床领域,并进一步讨论可能限制其未来临床转化的挑战。